Eckert & Ziegler SE (ETR:EUZ)

Market Cap	3.55B
Revenue (ttm)	299.27M
Net Income (ttm)	36.64M
Shares Out	189.58M
EPS (ttm)	0.58
PE Ratio	28.55
Forward PE	23.54
Dividend	0.02 (0.09%)
Ex-Dividend Date	Jun 19, 2025

Volume	267,474
Average Volume	144,693
Open	19.80
Previous Close	19.53
Day's Range	18.72 - 19.98
52-Week Range	12.27 - 23.25
Beta	1.55
RSI	35.49
Earnings Date	Aug 8, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynt...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2024
• Employees: 1,085
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: EUZ

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.